References 1. Antoniazzi F, Bertoldo F, Mottes M, et al: Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis. J Pediatr 129:432?439, 1996. Ovid Full Text Bibliographic Links Library Holdings [Context Link] 2. Antoniazzi F, Mottes M, Fraschini P, Brunelli PC, Tato L: Osteogenesis imperfecta: Practical treatment guidelines. Paediatr Drugs 2:465?488, 2000. Bibliographic Links Library Holdings [Context Link] 3. Astrom E, Soderhall S: Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta. Acta Paediatr 87:64?68, 1998. [Context Link] 4. Bailey RW: Further clinical experience with the extensible nail. Clin Orthop 159:171?176, 1981. Bibliographic Links Library Holdings [Context Link] 5. Bank RA, Robins SP, Wijmenga C, et al: Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: Indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17. Proc Natl Acad Sci USA 96:1054?1058, 1999. Bibliographic Links Library Holdings [Context Link] 6. Bateman JF, Chan D, Mascara T, Rogers JG, Cole WG: Collagen defects in lethal perinatal osteogenesis imperfecta. Biochem J 240:699?708, 1986. Bibliographic Links Library Holdings [Context Link] 7. Bateman JF, Chan D, Moeller I, Hannagan M, Cole WG: A 5? splice site mutation affecting the pre-mRNA splicing of two upstream exons in the collagen COL1A1 gene: Exon 8 skipping and altered definition of exon 7 generates truncated pro alpha 1(I) chains with a non-collagenous insertion destabilizing the triple helix. Biochem J 302:729?735, 1994. Bibliographic Links Library Holdings [Context Link] 8. Bateman JF, Moeller I, Hannagan M, Chan D, Cole WG: Lethal perinatal osteogenesis imperfecta due to a type I collagen alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatch. Hum Mutat 1:55?62, 1992. Bibliographic Links Library Holdings [Context Link] 9. Bembi B, Parma A, Bottega M, et al: Intravenous pamidronate treatment in osteogenesis imperfecta. J Pediatr 131:622?625, 1997. Ovid Full Text Bibliographic Links Library Holdings [Context Link] 10. Binder H, Conway A, Gerber LH: Rehabilitation approaches to children with osteogenesis imperfecta: A ten-year experience. Arch Phys Med Rehabil 74:386?390, 1993. Bibliographic Links Library Holdings [Context Link] 11. Boyde A, Travers R, Glorieux FH, Jones SJ: The mineralization density of iliac crest bone from children with osteogenesis imperfecta. Calcif Tissue Int 64:185?190, 1999. Full Text Bibliographic Links Library Holdings [Context Link] 12. Brenner RE, Vetter U, Worsdorfer O, et al: Biochemical analysis of bone compacta in osteogenesis imperfecta. Ann N Y Acad Sci 543:106?108, 1988. Bibliographic Links Library Holdings [Context Link] 13. Byers PH: Osteogenesis imperfecta: Perspectives and opportunities. Curr Opin Pediatr 12:603?609, 2000. Bibliographic Links Library Holdings [Context Link] 14. Byers PH, Bonadio JF, Cohn DH, et al: Osteogenesis imperfecta: The molecular basis of clinical heterogeneity. Ann N Y Acad Sci 543:117?128, 1988. Bibliographic Links Library Holdings [Context Link] 15. Byers PH, Wallis GA, Willing MC: Osteogenesis imperfecta: Translation of mutation to phenotype. J Med Genet 28:433?442, 1991. Bibliographic Links Library Holdings [Context Link] 16. Casci T: Technology. ChIP on chips. Nat Rev Genet 2:88, 2001. Bibliographic Links Library Holdings [Context Link] 17. Chiodo AA, Hockey A, Cole WG: A base substitution at the splice acceptor site of intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII. J Biol Chem 267:6361?6396, 1992. Bibliographic Links Library Holdings [Context Link] 18. Chu ML, Williams CJ, Pepe G, et al: Internal deletion in a collagen gene in a perinatal lethal form of osteogenesis imperfecta. Nature 304:78?80, 1983. Bibliographic Links Library Holdings [Context Link] 19. Cohn DH, Starman BJ, Blumberg B, Byers PH: Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COL1A1). Am J Hum Genet 46:591?601, 1990. Bibliographic Links Library Holdings [Context Link] 20. Cole DE, Carpenter TO: Bone fragility, craniosynostosis, ocular proptosis, hydrocephalus, and distinctive facial features: A newly recognized type of osteogenesis imperfecta. J Pediatr 110:76?80, 1987. Bibliographic Links Library Holdings [Context Link] 21. Cole WG: Orthopaedic treatment of osteogenesis imperfecta. Ann N Y Acad Sci 543:157?166, 1988. Bibliographic Links Library Holdings [Context Link] 22. Cole WG: Early surgical management of severe forms of osteogenesis imperfecta. Am J Med Genet 45:270?274, 1993. Bibliographic Links Library Holdings [Context Link] 23. Cole WG: The molecular pathology of osteogenesis imperfecta. Clin Orthop 343:235?248, 1997. Ovid Full Text Bibliographic Links Library Holdings [Context Link] 24. Cole WG, Chan D, Chambers GW, Walker ID, Bateman JF: Deletion of 24 amino acids from the proalpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VII. J Biol Chem 261:5496?5503, 1986. Bibliographic Links Library Holdings [Context Link] 25. Cole WG, Dalgleish R: Perinatal lethal osteogenesis imperfecta. J Med Genet 32:284?289, 1995. Ovid Full Text Bibliographic Links Library Holdings [Context Link] 26. Cole WG, Patterson E, Bonadio J, Campbell PE, Fortune DW: The clinicopathological features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by valine in the pro alpha 1 (I) chain of type I procollagen. J Med Genet 29:112?118, 1992. Bibliographic Links Library Holdings [Context Link] 27. Devogelaer JP, Malghem J, Maldague B, Nagant de Deuxchaisnes C: Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta. Skeletal Radiol 16:360?363, 1987. Full Text Bibliographic Links Library Holdings [Context Link] 28. Digirolamo CM, Stokes D, Colter D, et al: Propagation and senescence of human marrow stromal cells in culture: A simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107:275?281, 1999. Ovid Full Text Bibliographic Links Library Holdings [Context Link] 29. Engelbert RH, Gerver WJ, Breslau-Siderius LJ, et al: Spinal complications in osteogenesis imperfecta: 47 patients 1?16 years of age. Acta Orthop Scand 69:283?286, 1998. Bibliographic Links Library Holdings [Context Link] 30. Fedarko NS, Moerike M, Brenner R, Robey PG, Vetter U: Extracellular matrix formation by osteoblasts from patients with osteogenesis imperfecta. J Bone Miner Res 7:921?930, 1992. Bibliographic Links Library Holdings [Context Link] 31. Giunta C, Superti-Furga A, Spranger S, Cole WG, Steinmann B: Ehlers-Danlos syndrome type VII: Clinical features and molecular defects. J Bone Joint Surg 81A:225?238, 1999. Bibliographic Links Library Holdings [Context Link] 32. Glorieux FH: Bisphosphonate therapy for severe osteogenesis imperfecta. J Pediatr Endocrinol Metab 13 (Suppl):989?992, 2000. Bibliographic Links Library Holdings [Context Link] 33. Glorieux FH, Bishop NJ, Plotkin H, et al: Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339:947?952, 1998. [Context Link] 34. Glorieux FH, Rauch F, Plotkin H, et al: Type V osteogenesis imperfecta: A new form of brittle bone disease. J Bone Miner Res 15:1650?1658, 2000. Bibliographic Links Library Holdings [Context Link] 35. Gong Y, Slee RB, Fukai N, et al: LDL receptorrelated protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513?523, 2001. Full Text Bibliographic Links Library Holdings [Context Link] 36. Grassi G, Marini JC: Ribozymes: Structure, function, and potential therapy for dominant genetic disorders. Ann Med 28:499?510, 1996. Bibliographic Links Library Holdings [Context Link] 37. Hanscom DA, Winter RB, Lutter L, et al: Osteogenesis imperfecta: Radiographic classification, natural history, and treatment of spinal deformities. J Bone Joint Surg 74A:598?616, 1992. Bibliographic Links Library Holdings [Context Link] 38. Hayes M, Parker G, Ell J, Sillence D: Basilar impression complicating osteogenesis imperfecta type IV: The clinical and neuroradiological findings in four cases. J Neurol Neurosurg Psychiatry 66:357?364, 1999. Ovid Full Text Bibliographic Links Library Holdings [Context Link] 39. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al: Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309?313, 1999. Bibliographic Links Library Holdings [Context Link] 40. Horwitz EM, Prockop DJ, Gordon PL, et al: Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97:1227?1231, 2001. Bibliographic Links Library Holdings [Context Link] 41. Janus GJ, Finidori G, Engelbert RH, Pouliquen M, Pruijs JE: Operative treatment of severe scoliosis in osteogenesis imperfecta: Results of 20 patients after halo traction and posterior spondylodesis with instrumentation. Eur Spine J 9:486?491, 2000. Full Text Bibliographic Links Library Holdings [Context Link] 42. Jerosch J, Mazzotti I, Tomasevic M: Complications after treatment of patients with osteogenesis imperfecta with a Bailey-Dubow rod. Arch Orthop Trauma Surg 117:240?245, 1998. Full Text Bibliographic Links Library Holdings [Context Link] 43. Jones SJ, Glorieux FH, Travers R, Boyde A: The microscopic structure of bone in normal children and patients with osteogenesis imperfecta: A survey using backscattered electron imaging. Calcif Tissue Int 64:8?17, 1999. Full Text Bibliographic Links Library Holdings [Context Link] 44. Karbowski A, Schwitalle M, Brenner R, et al: Experience with Bailey-Dubow rodding in children with osteogenesis imperfecta. Eur J Pediatr Surg 10:119?124, 2000. Bibliographic Links Library Holdings [Context Link] 45. Krebsbach PH, Kuznetsov SA, Satomura K, et al: Bone formation in vivo: Comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63:1059?1069, 1997. Ovid Full Text Bibliographic Links Library Holdings [Context Link] 46. Landsmeer-Beker EA, Massa GG, Maaswinkel-Mooy PD, van de Kamp JJ, Papapoulos SE: Treatment of osteogenesis imperfecta with the bisphosphonate olpadronate (dimethylaminohydroxypropylidene bisphosphonate). Eur J Pediatr 156:792?794, 1997. Full Text Bibliographic Links Library Holdings [Context Link] 47. Li YH, Chow W, Leong JC: The Sofield-Millar operation in osteogenesis imperfecta. A modified technique. J Bone Joint Surg 82B:11?16, 2000. [Context Link] 48. Marini JC, Bordenick S, Heavner G, Rose S, Chrousos GP: Evaluation of growth hormone axis and responsiveness to growth stimulation of short children with osteogenesis imperfecta. Am J Med Genet 45:261?264, 1993. Bibliographic Links Library Holdings [Context Link] 49. Marini JC, Bordenick S, Heavner G, et al: The growth hormone and somatomedin axis in short children with osteogenesis imperfecta. J Clin Endocrinol Metab 76:251?256, 1993. Bibliographic Links Library Holdings [Context Link] 50. Marini JC, Gerber NL: Osteogenesis imperfecta: Rehabilitation and prospects for gene therapy. JAMA 277:746?750, 1997. Ovid Full Text Bibliographic Links Library Holdings [Context Link] 51. McAllion SJ, Paterson CR: Causes of death in osteogenesis imperfecta. J Clin Pathol 49:627?630, 1996. [Context Link] 52. Mulpuri K, Joseph B: Intramedullary rodding in osteogenesis imperfecta. J Pediatr Orthop 20:267?273, 2000. Bibliographic Links Library Holdings [Context Link] 53. Nicholls AC, Osse G, Schloon HG, et al: The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta. J Med Genet 21:257?262, 1984. Bibliographic Links Library Holdings [Context Link] 54. Niyibizi C, Smith P, Mi Z, Robbins P, Evans C: Potential of gene therapy for treating osteogenesis imperfecta. Clin Orthop 379 (Suppl):126?133, 2000. [Context Link] 55. Nuytinck L, Freund M, Lagae L, et al: Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen. Am J Hum Genet 66:1398?1402, 2000. Bibliographic Links Library Holdings [Context Link] 56. Osebold WR, Yamamoto SK, Hurley JH: The variability of response of scoliotic spines to segmental spinal instrumentation. Spine 17:1174?1179, 1992. Bibliographic Links Library Holdings [Context Link] 57. Oyama M, Tatlock A, Fukuta S, et al: Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging. Gene Ther 6:321?329, 1999. Bibliographic Links Library Holdings [Context Link] 58. Paterson CR: Clinical variability and life expectancy in osteogenesis imperfecta. Clin Rheumatol 14:228, 1995. Letter. [Context Link] 59. Paterson CR, McAllion S, Miller R: Heterogeneity of osteogenesis imperfecta type I. J Med Genet 20:203?205, 1983. Bibliographic Links Library Holdings [Context Link] 60. Paterson CR, McAllion S, Stellman JL: Osteogenesis imperfecta after the menopause. N Engl J Med 310:1694?1696, 1984. Bibliographic Links Library Holdings [Context Link] 61. Paterson CR, Ogston SA, Henry RM: Life expectancy in osteogenesis imperfecta. Br Med J 312:351, 1996. [Context Link] 62. Pereira RF, O?Hara MD, Laptev AV, et al: Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci U S A 95:1142?1147, 1998. Bibliographic Links Library Holdings [Context Link] 63. Phillips CL, Bradley DA, Schlotzhauer CL, et al: Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density. Bone 27:219?226, 2000. Bibliographic Links Library Holdings [Context Link] 64. Phinney DG, Kopen G, Righter W, et al: Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 75:424?436, 1999. Full Text Bibliographic Links Library Holdings [Context Link] 65. Plotkin H, Rauch F, Bishop NJ, et al: Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J Clin Endocrinol Metab 85:1846?1850, 2000. Ovid Full Text Bibliographic Links Library Holdings [Context Link] 66. Porat S, Heller E, Seidman DS, Meyer S: Functional results of operation in osteogenesis imperfecta: Elongating and nonelongating rods. J Pediatr Orthop 11:200?203, 1991. Bibliographic Links Library Holdings [Context Link]